skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

21 Total results for product and free and sample content found

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Drug Pricing Response: The 1,000-Day Report

Drug Pricing Response: The 1,000-Day Report

HHS’ “First 100 Days” take on the drug pricing “Blueprint” is a novel use of a tried-and-true milestone for presidential action. But it is probably more enlightening to look at what has happened in the 1,000 days since drug pricing became the overwhelming focus of political attention.

Topic us-election

Medtech Insight: 世界の医療機器・医療技術の最新情報

Inspection Tips Experimentation And Trump

Inspection Tips Experimentation And Trump

2017 was obviously dominated by news of political chaos coming out of the White House and, for the medtech industry

Topic us-election

Medtech Insight: 世界の医療機器・医療技術の最新情報

Public Citizen Challenges Trump's Regulation Executive Order

Public Citizen Challenges Trump's Regulation Executive Order

A lawsuit claims that Trump overstepped presidential authority.

Topic us-election

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Biotech Execs Speak Out Against Trump's Immigration Ban

Biotech Execs Speak Out Against Trump's Immigration Ban

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.

Topic press-release us-election

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Rogue FDA Tweeters Archive Inspection Data, Fearing Deletion By Trump

Rogue FDA Tweeters Archive Inspection Data, Fearing Deletion By Trump

Followers of rogue FDA twitter site AltFDA answered a call to back up inspection citations data the Obama administration made public in case the Trump administration erases it from the FDA website.

Topic us-election

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Big Pharma Subdued In Its Response To Trump's Travel EO

Big Pharma Subdued In Its Response To Trump's Travel EO

Big pharma has been muted in its response to President Trump's executive order imposing severe travel restrictions on nationals from seven Muslim-majority countries for 90 days. Small biotech, however, has no reservations about speaking out against the so-called 'immigration ban'.

Topic us-election Policy and regulation

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

IDMA Meet: Trump, Protectionism, New Markets And Cricket

IDMA Meet: Trump, Protectionism, New Markets And Cricket

The Trump presidency and the threat of protectionism, new generic opportunities beyond the US market, and the need for new quality benchmarks were some of the key issues discussed at the recent annual day celebrations of the Indian Drug Manufacturers’ Association.

Topic strategy us-election

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

Incoming president not holding over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.

Topic us-election fda

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

The Bully Pulpit: Trump Versus Drug Prices

The Bully Pulpit: Trump Versus Drug Prices

Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?

Topic us-election

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。